About
Technology
Issues
FAQ
Search
Scientometrics
Impact Factor
Discipline Ranks
h
-index
g
-index
Articles
Citations
Article Citations
Citation Distribution
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Journals
›
Clinical and Translational Immunology
›
top-articles
Clinical and Translational Immunology
5.0
(top 5%)
impact factor
548
(top 50%)
papers
13.8K
(top 20%)
citations
55
(top 10%)
h
-index
5.1
(top 5%)
impact factor
771
all documents
15.8K
doc citations
90
(top 10%)
g
-index
Top Articles
#
Title
Journal
Year
Citations
1
Regulation of immune cell function by short‐chain fatty acids
Clinical and Translational Immunology
2016
885
2
Detection of IgM and IgG antibodies in patients with coronavirus disease 2019
Clinical and Translational Immunology
2020
281
3
Furin‐mediated protein processing in infectious diseases and cancer
Clinical and Translational Immunology
2019
231
4
Microbiome effects on immunity, health and disease in the lung
Clinical and Translational Immunology
2017
225
5
Toll‐like receptors: the swiss army knife of immunity and vaccine development
Clinical and Translational Immunology
2016
216
6
Selecting costimulatory domains for chimeric antigen receptors: functional and clinical considerations
Clinical and Translational Immunology
2019
205
7
Dietary metabolites and the gut microbiota: an alternative approach to control inflammatory and autoimmune diseases
Clinical and Translational Immunology
2016
196
8
Dengue virus antibodies enhance Zika virus infection
Clinical and Translational Immunology
2016
179
9
Maternal and infant infections stimulate a rapid leukocyte response in breastmilk
Clinical and Translational Immunology
2013
172
10
Infectious mononucleosis
Clinical and Translational Immunology
2015
167
11
MAIT cells: new guardians of the liver
Clinical and Translational Immunology
2016
160
12
Targeting dendritic cells: a promising strategy to improve vaccine effectiveness
Clinical and Translational Immunology
2016
152
13
Chronic mucocutaneous candidiasis disease associated with inborn errors of IL‐17 immunity
Clinical and Translational Immunology
2016
148
14
Vaccines to prevent leishmaniasis
Clinical and Translational Immunology
2014
142
15
Roles of the intestinal microbiota in pathogen protection
Clinical and Translational Immunology
2017
142
16
From mouse to man: safety, immunogenicity and efficacy of a candidate leishmaniasis vaccine LEISH‐F3+GLA‐SE
Clinical and Translational Immunology
2015
131
17
Epstein–barr virus vaccines
Clinical and Translational Immunology
2015
128
18
Epstein–Barr virus and multiple sclerosis: potential opportunities for immunotherapy
Clinical and Translational Immunology
2014
120
19
Recent novel approaches to limit oxidative stress and inflammation in diabetic complications
Clinical and Translational Immunology
2018
119
20
Immune microenvironment composition in non‐small cell lung cancer and its association with survival
Clinical and Translational Immunology
2020
119
21
Clinical efficacy of intravenous immunoglobulin therapy in critical ill patients with COVID‐19: a multicenter retrospective cohort study
Clinical and Translational Immunology
2020
111
22
Clinical immune‐monitoring strategies for predicting infection risk in solid organ transplantation
Clinical and Translational Immunology
2014
107
23
Caspase‐8: not so silently deadly
Clinical and Translational Immunology
2017
105
24
Lessons from ten years of genome‐wide association studies of asthma
Clinical and Translational Immunology
2017
103
25
OX40, PD‐1 and CTLA‐4 are selectively expressed on tumor‐infiltrating T cells in head and neck cancer
Clinical and Translational Immunology
2016
102
26
Histone deacetylases in monocyte/macrophage development, activation and metabolism: refining HDAC targets for inflammatory and infectious diseases
Clinical and Translational Immunology
2016
96
27
Regulatory T‐cell heterogeneity and the cancer immune response
Clinical and Translational Immunology
2017
96
28
Clinical application of genetically modified T cells in cancer therapy
Clinical and Translational Immunology
2014
94
29
Human
FOXP
3
+
T regulatory cell heterogeneity
Clinical and Translational Immunology
2018
93
30
Treg activation defect in type 1 diabetes: correction with TNFR2 agonism
Clinical and Translational Immunology
2016
91
31
Embracing the gut microbiota: the new frontier for inflammatory and infectious diseases
Clinical and Translational Immunology
2017
90
32
Defective T‐cell control of Epstein–Barr virus infection in multiple sclerosis
Clinical and Translational Immunology
2017
90
33
Transforming growth factor β: a master regulator of the gut microbiota and immune cell interactions
Clinical and Translational Immunology
2017
89
34
Cytokines in type 1 diabetes: mechanisms of action and immunotherapeutic targets
Clinical and Translational Immunology
2020
88
35
Endothelial cells are not productively infected by SARS‐CoV‐2
Clinical and Translational Immunology
2021
88
36
Bacterial lipodipeptide, Lipid 654, is a microbiome‐associated biomarker for multiple sclerosis
Clinical and Translational Immunology
2013
87
37
New insights into therapeutic strategies for gut microbiota modulation in inflammatory diseases
Clinical and Translational Immunology
2016
85
38
Genome‐wide association studies in Crohn's disease: Past, present and future
Clinical and Translational Immunology
2018
80
39
Antibodies against type I interferon: detection and association with severe clinical outcome in COVID‐19 patients
Clinical and Translational Immunology
2021
79
40
Interleukin‐6: a new therapeutic target in systemic sclerosis?
Clinical and Translational Immunology
2013
78
41
Clinical development methodology for infusion‐related reactions with monoclonal antibodies
Clinical and Translational Immunology
2015
77
42
Local innate immune responses in the vaccine adjuvant‐injected muscle
Clinical and Translational Immunology
2016
77
43
Infiltrating monocytes in liver injury and repair
Clinical and Translational Immunology
2016
75
44
Endoplasmic reticulum stress in the development of multiple myeloma and drug resistance
Clinical and Translational Immunology
2018
74
45
Adoptive T‐cell therapy: adverse events and safety switches
Clinical and Translational Immunology
2014
73
46
Targeted therapeutics in SLE: emerging strategies to modulate the interferon pathway
Clinical and Translational Immunology
2016
72
47
Guanylate‐binding protein 5 is a marker of interferon‐γ‐induced classically activated macrophages
Clinical and Translational Immunology
2016
71
48
Type 1 diabetes genome‐wide association studies: not to be lost in translation
Clinical and Translational Immunology
2017
70
49
Plasmacytoid dendritic cell biology and its role in immune‐mediated diseases
Clinical and Translational Immunology
2020
70
50
Stem memory T cells (TSCM)—their role in cancer and HIV immunotherapies
Clinical and Translational Immunology
2014
68
site/software ©
exaly
; All materials licenced under
CC by-SA
.